Literature DB >> 12601350

Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.

Tsutomu Masaki1, Yasushi Shiratori, William Rengifo, Kouichi Igarashi, Michiko Yamagata, Kazutaka Kurokohchi, Naohito Uchida, Yoshiaki Miyauchi, Hitoshi Yoshiji, Seishiro Watanabe, Masao Omata, Shigeki Kuriyama.   

Abstract

Increasing evidence has indicated that perturbation of cyclins is one of the major factors leading to cancer. The aim of this study was not only to investigate various cell cycle-related kinase activities in hepatocellular carcinoma (HCC), but also to analyze the difference of cell cycle-related kinase activity levels between hepatitis C virus (HCV)-induced HCC and HCV-induced cirrhosis. The protein levels of cyclins D1, E, A, and H, and of cyclin dependent kinase 1 (Cdk1), Cdk2, Cdk4, Cdk6, and Cdk7 in HCC and in surrounding nontumorous cirrhosis were determined by Western blot. The enzymatic activities of cyclins D1, E, A, Cdk1, Cdk4, Cdk6, Cdk7, and Wee1 were measured using in vitro kinase assays. Protein levels and kinase activities of cyclin D1, Cdk4, cyclin E, cyclin A, and Wee1 were significantly elevated in HCC compared with surrounding cirrhotic tissues. The enhanced cyclin D1-related kinase activity in HCC was accompanied by the up-regulation of Cdk4 activity, but not Cdk6 activity. The kinase activities of Cdk6, Cdk7, and Cdk1 did not differ between HCC and surrounding cirrhotic tissues. In addition, the protein levels and kinase activities of cyclin D1, Cdk4, and cyclin E were higher in poorly differentiated HCC and advanced HCC. In conclusion, the increases of cyclin D1, Cdk4, cyclin E, cyclin A, and Wee1 play an important role in the development of HCC from cirrhosis. Cyclin D1, Cdk4, and cyclin E activation may be closely related to the histopathologic grade and progression of HCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601350     DOI: 10.1053/jhep.2003.50112

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  62 in total

1.  The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells.

Authors:  Uta Kossatz; Kai Breuhahn; Benita Wolf; Matthias Hardtke-Wolenski; Ludwig Wilkens; Doris Steinemann; Stephan Singer; Felicitas Brass; Stefan Kubicka; Brigitte Schlegelberger; Peter Schirmacher; Michael P Manns; Jeffrey D Singer; Nisar P Malek
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

2.  Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy.

Authors:  Christopher J Matheson; Kimberly A Casalvieri; Donald S Backos; Philip Reigan
Journal:  ChemMedChem       Date:  2018-07-11       Impact factor: 3.466

3.  Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract.

Authors:  Zong-Fang Li; Zhi-Dong Wang; Yuan-Yuan Ji; Shu Zhang; Chen Huang; Jun Li; Xian-Ming Xia
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

Review 4.  Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.

Authors:  David R Raleigh; Daphne A Haas-Kogan
Journal:  Future Oncol       Date:  2013-02       Impact factor: 3.404

5.  Transactivating effect of complete S protein of hepatitis B virus and cloning of genes transactivated by complete S protein using suppression subtractive hybridization technique.

Authors:  Gui-Qin Bai; Yan Liu; Jun Cheng; Shu-Lin Zhang; Ya-Fei Yue; Yan-Ping Huang; Li-Ying Zhang
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

Review 6.  Wee1 kinase as a target for cancer therapy.

Authors:  Khanh Do; James H Doroshow; Shivaani Kummar
Journal:  Cell Cycle       Date:  2013-08-26       Impact factor: 4.534

7.  Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.

Authors:  Carlee E Ashley; Eric C Carnes; Genevieve K Phillips; Paul N Durfee; Mekensey D Buley; Christopher A Lino; David P Padilla; Brandy Phillips; Mark B Carter; Cheryl L Willman; C Jeffrey Brinker; Jerri do Carmo Caldeira; Bryce Chackerian; Walker Wharton; David S Peabody
Journal:  ACS Nano       Date:  2011-06-07       Impact factor: 15.881

8.  Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.

Authors:  Jonathan Choiniere; Jianguo Wu; Li Wang
Journal:  Mol Pharmacol       Date:  2016-12-21       Impact factor: 4.436

9.  Expression and prognostic value of the WEE1 kinase in gliomas.

Authors:  Darija Music; Rikke Hedegaard Dahlrot; Simon Kjær Hermansen; Jacob Hjelmborg; Karin de Stricker; Steinbjørn Hansen; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2016-01-06       Impact factor: 4.130

10.  Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells.

Authors:  Wei Wei; Mei-Sze Chua; Susan Grepper; Samuel K So
Journal:  Mol Cancer       Date:  2009-09-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.